SCHEMBL7095976

SCHEMBL7095976

O=C(CN1CCOCC1)Nc1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 4/20 0.55
PARP1 P09874 1/20 0.54
CCNE2 O96020 4/20 0.53
CDK4 P11802 4/20 0.53
CCND1 P24385 4/20 0.53
CCNE1 P24864 4/20 0.53
CDK2 P24941 4/20 0.53
LMNA P02545 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
KDR P35968 3/20 0.52
ALDH1A1 P00352 5/20 0.52
HPGD P15428 2/20 0.52
KDM4E B2RXH2 1/20 0.52
NPC1 O15118 1/20 0.52
TP53 P04637 1/20 0.52
RAB9A P51151 1/20 0.52
HSD17B10 Q99714 1/20 0.52
KIT P10721 1/20 0.49
FLT1 P17948 1/20 0.49
MGLL Q99685 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6996897 0.92 CHEK1 (0.65) CHEK1PARP1LMNAKDR
SCHEMBL7000955 0.90 KDR (0.65) CHEK1CCNE2CDK4CCND1CCNE1
SCHEMBL6999383 0.90 KDR (0.54) CHEK1CCNE2CCNE1CDK2KDR
SCHEMBL6998835 0.90 KDR (0.53) CHEK1CCNE2CDK4CCND1CCNE1
SCHEMBL7091559 0.89 CHEK1 (0.59) CHEK1PARP1CCNE2CDK4CCND1
SCHEMBL6996857 0.87 KDR (0.61) CHEK1CCNE2CDK4CCND1CCNE1
SCHEMBL7092301 0.86 KDR (0.50) CHEK1CCNE2CDK4CCND1CCNE1
SCHEMBL7701720 0.85 CHEK1 (0.54) CHEK1LMNASMN1; SMN2KDRNPC1
SCHEMBL4818061 0.85 CHEK1 (0.68) CHEK1KDR
SCHEMBL7700703 0.85 CHEK1 (0.53) CHEK1CDK2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed